Orgenesis Inc at SNN Network Summer Event (Virtual) Transcript
Good morning, everyone, and welcome to our first presentation and presenter of the day at the SNN Network Summer Virtual Event. I'm very pleased to introduce Vered Caplan, CEO of Orgenesis, publicly traded company, the symbol is ORGS on Nasdaq.
Vered, the floor is yours.
Hi. Thank you, everyone, for coming to listen to the presentation. Wish it could be in person, but maybe next year.
So I wanted to present Orgenesis today, and we are a publicly traded company. So please read carefully the forward-looking statements.
And as I kind of tell you a little bit about the background of the Orgenesis, I just want to say that our focus is really cell and gene therapies. Cell and gene therapies is one of the fastest growing spaces in biotech. It's one of the most exciting spaces in biotech. And I don't know, I think the slides here are going a bit slow. I'll continue, and we'll start to resolve this as we go along.
And one of the things that we try to do is take this new space in biotech and make
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |